Literature DB >> 22648799

Subsequent publication rate of studies from India presented at the annual congresses of SIOP.

Ramandeep Singh Arora1, Puneet Arora, Vinod Prabhu, Tim Eden.   

Abstract

Subsequent publication as a complete manuscript is a desirable end-point for studies presented at scientific meetings. Between 2001 and 2005, 191 studies from India were presented at annual congresses of the International Society of Paediatric Oncology. Of these 24 (12.6%) were published with a median time to publication of 20 months. This subsequent publication rate is lower than previous reports of SPR for either paediatric or oncological meetings. A lower proportion of oral presentations and randomised clinical trials (RCTs) could partly explain our findings. Further research is needed to understand barriers to subsequent publication of presented data from India.

Entities:  

Mesh:

Year:  2012        PMID: 22648799     DOI: 10.1002/pbc.24102

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  2 in total

1.  Full publication of results initially presented in abstracts.

Authors:  Roberta W Scherer; Joerg J Meerpohl; Nadine Pfeifer; Christine Schmucker; Guido Schwarzer; Erik von Elm
Journal:  Cochrane Database Syst Rev       Date:  2018-11-20

Review 2.  Challenges in launching multinational oncology clinical trials in India.

Authors:  Kamal S Saini; Gaurav Agarwal; Ramesh Jagannathan; Otto Metzger-Filho; Monika L Saini; Khurshid Mistry; Raghib Ali; Sudeep Gupta
Journal:  South Asian J Cancer       Date:  2013-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.